Atlas Venture Opportunity Fund I, L.P. - Insider Trading & Ownership

Entity
Company
Location
400 Technology Square, 10 Th Floor, Cambridge, MA
Summary
The estimated value of insider holdings of Atlas Venture Opportunity Fund I, L.P. is at least $78.6M dollars as of March 5, 2024. Atlas Venture Opportunity Fund I, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $69.3M. Atlas Venture Opportunity Fund I, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $9.27M.
All Insider Reports
All Insider Reports

Ownership of Atlas Venture Opportunity Fund I, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. 10%+ Owner $69.3M -$1.4M -1.98% Mar 1, 2024
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $9.27M Jul 1, 2022

Insider Transactions Reported by Atlas Venture Opportunity Fund I, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.